Lv51
1040 积分 2023-11-14 加入
Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE
1个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
3个月前
已完结
A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma
3个月前
已关闭
Adenocarcinoma in situ of the uterine cervix: Clinical practice guidelines from the Italian society of colposcopy and cervical pathology (SICPCV)
3个月前
已关闭
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
3个月前
已完结
Journey of the elimination of cervical cancer in China
4个月前
已关闭
[Infection of human papillomavirus and head and neck cancer]
4个月前
已完结
Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings
4个月前
已完结
Advances in the management of endometrial cancer
4个月前
已完结
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination
5个月前
已完结
皖公网安备34019202002308
